DNA discovery points to new clinical biomarker in predicting breast cancer risk
Scientists have identified a new biomarker in the blood that could help identify more women at an increased risk of breast cancer. Such women might benefit from risk-reducing measures. In a prospective study, researchers from Imperial College London and the Human Genetics Foundation (HuGeF) in Torino, Italy, have concluded that DNA methylation levels in blood […]
